GENE ONLINE|News &
Opinion
Blog

M&A
Sherlock Biosciences Buys Sense Biodetection to Accelerate CRISPR-Based Handheld Diagnostic Tests
2023-02-02
JPM23: Acquisition Announcements From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Italy’s Chiesi Buys Rare Disease Player Amryt For $1.48 Billion
2023-01-09
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Kite Buys Tmunity To Chase Next-Generation CAR T-Cell Therapies
2022-12-21
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
Amgen Leads the Pack After Sanofi Drops Out of Horizon Bid
2022-12-11
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Kriya Scoops Up Redpin to Break into Neurology Gene Therapies
2022-11-16
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
1 2 3 12
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!